News

Our breast cancer clinical research consortium continues to grow and expands to 15 member institutions across Quebec and Ontario.

After the Ottawa Hospital, the Sunnybrook Research Institute has now joined the consortium to provide patients in the Greater Toronto Area with better access to clinical trials in breast cancer.

The Group is proud to announce that the CISSS des Laurentides – Hôpital de Saint-Jérôme has joined the consortium which now includes 13 hospitals across Quebec.

The Group highlighted the commitment of the Hôpital Charles-Le Moyne to breast cancer treatment research by unveiling a recognition plaque that will adorn a wall of Centre intégré de cancérologie de la Montérégie.

Our Group and The Ottawa Hospital announce a collaboration that will make it easier for people living in Outaouais and Eastern Ontario to access breast cancer clinical trials.

Our Group is one of the largest breast cancer clinical research consortia in Canada bringing together 14 hospitals […]

Held on October 15th, the Group’s annual meeting brought together representatives of the Group’s member hospitals […]

Audace au Féminin and the McPeak-Sirois Group become partners in the Tétons Ben Drôles campaign to improve awareness of clinical research in breast cancer for Black and racialized women […]

Une trentaine de patient.e.s et proches ont participé à une conférence grand public gratuite sur le thème « Démystifier la recherche clinique » à Shawinigan en Mauricie. Available in French only […]

Eight years ago, the McPeak-Sirois Group for clinical research in breast cancer launched its operations and it has since become one of the largest breast cancer clinical research consortia in Canada.

We are very proud to announce that Mrs. Susan McPeak and Mr. Charles Sirois, co-founders of the McPeak-Sirois Group, were awarded the Meritorious Service Cross (Civil Division) […]

Our Group and the CISSS de Chaudière-Appalaches will collaborate to enable people with breast cancer to have better access to clinical trials in the region […]

We are proud to announce that Breast Cancer Canada grants $2.5 Million to our Group to expand access to clinical research throughout Quebec […]

The Group recently highlighted the commitment of the Montréal West Island CIUSSS – St-Mary’s Hospital Centre as an affiliated member of the Group during the unveiling ceremony of a recognition plaque. […]

Dr. Julie Lemieux will present on the first Quebec metastatic breast cancer registry, an initiative of the McPeak-Sirois Group, at San Antonio Breast Cancer Symposium […]

Près de 100 personnes ont participé au Colloque sur la recherche qui soigne qui s’est tenu le samedi 14 octobre en présentiel à l’Hôtel Mortagne à Boucherville ainsi qu’en virtuel […]

The CISSS de Lanaudière joins the McPeak-Sirois Group and this collaboration will enable breast cancer patients to have better access to clinical trials in that region […]

The McPeak-Sirois Group is pleased to announce that Seagen Canada has joined the Quebec Metastatic Breast Cancer Registry as partner […]

The Group’s annual meeting was an opportunity for the founding couple to announce that the Programme Accès-recherche, was renamed Programme Accès-recherche Dr André-Robidoux in tribute to the founding president of the scientific committee.[…]

Our Group is proud to announce that by joining forces with the Canadian Cancer Society, it will expand participation in the Quebec Metastatic Breast Cancer Registry initiated its Executive Scientific Committee […]

Composed of research coordinators who have been assigned by their institution to the clinical trials conducted within the Group, the Coordination Committee ensures the smooth running and cohesion of the consortium’s operations. […]

The McPeak-Sirois Group and MUHC are pleased to announce the launch of the Quebec Metastatic Breast Cancer Registry, a project initiated by investigators sitting on the Executive Scientific Committee of the Group […]

The strength of our unique Group lies mainly in the willingness of public institutions to pool their strengths, expertise and experiences with respect to best practices based on Research that cares […]

The McPeak-Sirois Group is proud to have contributed to the article entitled “Patient and Patient Group Engagement in Cancer Clinical Trials: A Stakeholder Charter”[…]

As part of Breast Cancer Awareness Month, we are pleased to pay tribute to Dr. Robidoux, Surgical Oncologist at the CHUM and Founding President of the Executive Scientific Committee of the McPeak-Sirois Group[…]

The unveiling of a plaque acknowledging the commitment of the CIUSSS de l’Est-de-l’Île-de-Montréal – Hôpital Maisonneuve-Rosemont as associate member of the McPeak-Sirois Group took place at the Hôpital Maisonneuve-Rosemont on Tuesday, October 15th. […]

On Sunday, July 7th, La Presse + published an interview with Susan McPeak in the section “Personnalité de la semaine” (“Person of the Week”) […]

It is with great pride that Susan McPeak, co-founder of the McPeak-Sirois Group, was recognized for her contribution to the fight against Breast Cancer on May 29th during the 6th edition of the Audacious benefit event […]

On Wednesday March 13th, a ceremony was held at the McGill University Health Centre (MUHC) Breast Clinic for the unveiling of a recognition plaque highlighting the hospital’s commitment as a founding institution of the McPeak-Sirois Group. […]

On April 4th 2018, Susan Mc Peak and Charles Sirois were awarded the National Bank Innovation in the Community Award during the Recognition Concert of the Quebec Breast Cancer Foundation. This price is awarded to people whose work has permitted the introduction of a remarkable innovation […]